Benign myoclonic epilepsy in infancy: neuropsychological and behavioural outcome

Salvatore Mangano1, Antonina Fontana, Liberia Cusumano

  • 1Dipartimento Materno Infantile, Unità di Neuropsichiatria Infantile, Università di Palermo, via Lancia di Brolo 10 bis, 90145 Palermo, Italy. manganos@katamail.com

Brain & Development
|March 2, 2005
PubMed

Insights

Benign myoclonic epilepsy in infancy (BMEI) often leads to long-term neurodevelopmental issues, despite its name. Early seizure onset and treatment delays contribute to poorer cognitive and behavioral outcomes in affected children.

Area of Science:

  • Pediatric Neurology
  • Developmental Neuroscience
  • Epileptology

Background:

  • Benign myoclonic epilepsy in infancy (BMEI) is a rare epilepsy syndrome.
  • Historically associated with a good prognosis, recent evidence suggests potential long-term neurodevelopmental challenges.

Purpose of the Study:

  • To investigate the long-term seizure outcome and neuropsychological evolution in children with BMEI.
  • To identify factors influencing the prognosis of BMEI.

Main Methods:

  • Long-term follow-up of seven patients diagnosed with BMEI.
  • Assessment of seizure control, cognitive function, and behavioral development.

Main Results:

  • 86% of patients exhibited neuropsychological and intellectual disorders at follow-up.
  • Disabilities included mental retardation, borderline IQ, fine motor deficits, attention deficits, language impairment, and learning disorders.
  • Early seizure onset, delayed treatment, and drug efficacy were identified as potential contributing factors.

Conclusions:

  • BMEI may interfere with developing functions, leading to persistent neuropsychological disabilities.
  • The prognosis of BMEI may be less favorable than previously thought, influenced by early onset and treatment factors.
  • BMEI's impact appears to be a gradual interference with development rather than an acute destructive effect.

Related Concept Videos